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T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
c o r r e s p o n d e n c e
Liberal or Restrictive Transfusion after Cardiac Surgery
To the Editor: In their article on red-cell trans-
fusion, Murphy et al. (March 12 issue)1 report 
substantial nonadherence to treatment in both 
study groups — one of which had a restrictive 
threshold for hemoglobin level in red-cell trans-
fusions and one of which had a liberal threshold. 
Although nonadherence (defined as either the 
failure to transfuse red cells within 24 hours after 
a patient’s hemoglobin fell below an assigned 
threshold or the administration of a transfusion 
when the hemoglobin level was above the as-
signed threshold) increases the likelihood of a 
null result for the primary outcome, it might con-
found the finding of increased 90-day mortality 
in the restrictive-threshold group, since patients in 
that group who received transfusions above the 
restrictive threshold were assumed to be sicker, 
whereas patients in the group with a liberal 
threshold were assumed to be healthier (and 
hence not receiving transfusions below the lib-
eral threshold). Did the authors observe an in-
crease in mortality in association with nonad-
herence to treatment in the restrictive-threshold 
group?
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To the Editor: Although the Transfusion Indi-
cation Threshold Reduction (TITRe2) trial was 
well designed and conducted, in the absence of 
a difference in the composite primary outcome, 
the finding of a significant between-group dif-
ference in 90-day mortality is perplexing. Should 
this finding be real, the authors do not provide a 
plausible physiological explanation; humans be-
come oxygen-supply–dependent at exceedingly low 
levels of oxygen delivery.1 Cardiopulmonary by-
pass surgery has been shown to cause hemolysis 
with the release of free hemoglobin, which scav-
enges nitric oxide and leads to impaired micro-
circulatory flow.2,3 In addition to hemolysis, the 
surgery causes sublethal damage to red cells that 
decreases their oxygen-carrying capacity and 
causes abnormalities in aggregation, deformabil-
ity, and blood viscosity from which a patient may 
need months to recover.4 These rheologic abnor-
malities may increase the patient’s subsequent 
risk of cardiovascular events.5 Is it possible that 
postoperative transfusion to a higher hemoglobin 
level may offset some of these rheologic abnor-
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malities? It is important that a confirmatory 
study be undertaken before a seismic change in 
transfusion practice occurs. Furthermore, it is 
important to emphasize that the findings of this 
study apply only to blood transfusions given after 
cardiopulmonary bypass surgery.
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To the Editor: The aim of blood transfusion is 
to increase the delivery of oxygen (DO2). In this 
regard, findings of the study by Murphy et al. are 
questionable since the study does not take into 
account the ratio of oxygen consumption (VO2) 
to delivery. This ratio can be determined by cal-
culating the central venous oxygen saturation 
(ScvO2) (ScVO2= 1 − [VO2/DO2]), a simple calcula-
tion that can be applied in the context of cardiac 
surgery.1 When applied in this way, ScvO2 is a 
determinant of individual metabolic tolerance to 
anemia. We have found that patients with similar 
hemoglobin values can be classified in two groups 
according to their ScvO2 values.2 Whereas trans-
fusions were beneficial in patients with low ScvO2 
values, no benefits were revealed for patients 
with normal ScvO2 values (>70%). Like others, we 
have suggested that transfusion should be trig-
gered by ScvO2 in patients with sepsis3 and after 
major surgery.1,2 Future large clinical trials 
should consider the clinical usefulness of ScvO2 
as an individual and physiological trigger for 
transfusion as compared with that of arbitrary 
fixed hemoglobin thresholds.
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To the Editor: Murphy et al. sought to compare 
two red-cell transfusion strategies for cardiac 
surgery, an important consideration given the cur-
rent variability in transfusion practices1 (despite 
recommendations by the Society of Thoracic Sur-
geons2). The title of the article is misleading, 
since their study is lacking a transfusion thresh-
old that would be considered to be truly restric-
tive. There were high rates of red-cell and blood-
component transfusions before randomization 
in both groups and very high rates of red-cell 
transfusion after randomization in both groups 
(63.7% in the restrictive-threshold group and 
94.9% in the liberal-threshold group) with the 
mean difference in hemoglobin nadirs being only 
1 g per deciliter. Despite efforts to create two dif-
ferent groups, the groups were similar, which 
makes it difficult to attach meaning to the out-
comes. At best, the study compared a liberal 
transfusion strategy with a more liberal transfu-
sion strategy.
Randomized clinical trials comparing restric-
tive and liberal transfusion practices are sorely 
needed. In the interim, the data from observa-
tional studies conducted by our group3 and by 
others4 strongly favor the restrictive approach 
and cannot be ignored.
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To the Editor: Murphy et al. found that a re-
strictive transfusion threshold after cardiac sur-
gery did not have a significant effect on the pri-
mary composite end point (a serious infection or 
an ischemic event) as compared with a liberal 
transfusion threshold. However, all-cause mor-
tality at 90 days was higher with the restrictive 
transfusion threshold. The analyses of the com-
posite primary end point and the secondary mor-
bidity end points did not take into account the 
competing risk of death and the resulting infor-
mative censoring.1-3 It is possible that some pa-
tients did not acquire an infection or have an is-
chemic event because they died before this could 
happen; since mortality was significantly higher 
in the restrictive-transfusion group, this possi-
bility may confound the conclusion regarding the 
safety of this intervention. Could the authors pro-
vide the number of patients in both groups who 
were alive and free of the composite end point at 
90 days? Also, could the time to weaning and 
discharge from the intensive care unit (ICU) or 
hospital be determined, given that nonsurvivors 
would then be penalized as never having been 
weaned or discharged? 4 These additional sensi-
tivity analyses might reveal that a restrictive 
transfusion threshold for this patient population 
is not only ineffective but also unsafe.
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To the Editor: Although patients requiring emer-
gency care were excluded from the study, we 
wonder why no distinction was made in the sub-
group analysis between patients for whom sur-
gery was elective and patients with an acute con-
dition (i.e., patients requiring urgent but not 
emergency surgery after myocardial infarction). 
It is well recognized that this latter group has 
higher rates of blood transfusion, a greater prev-
alence of preoperative anemia, and worse out-
comes.1
There is an important distinction between pa-
tients who receive elective surgery and may re-
main in the ICU for 24 to 48 hours and patients 
who are subject to the development of complica-
tions, who require a prolonged stay in the ICU, 
and who are subject to the development of ane-
mia (as occurs in >90% of patients who meet the 
first two criteria).2 In patients with sepsis (non-
cardiac), a liberal transfusion strategy confers no 
mortality benefit.3 The pathophysiological adap-
tation occurring in established critical illness and 
the complex interplay among erythropoietin, 
hepcidin, and possibly neocytolysis is clearly dif-
ferent from the acute stress response after major 
surgery.4 Does the transition between an elective 
surgical patient and a patient in need of critical 
care affect the point at which transfusion is trig-
gered? We are of the opinion that timing is every-
thing and that the important question is, when 
does a cardiac surgical patient become a critical 
care patient?
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The Authors Reply: Among patients in whom 
there was severe nonadherence to treatment, a 
higher proportion in the restrictive-threshold 
group died as compared with the liberal-thresh-
old group. However, this fact does not represent 
confounding. Although nonadherence in the re-
strictive-threshold group occurred among pa-
tients who were sicker than others, at random-
ization there would have been similar numbers 
of sicker patients in both groups, with those in 
the liberal-threshold group receiving transfusions 
in accordance with the protocol.
No study has shown a causal relationship 
between red-cell transfusion and hemolysis, the 
release of free hemoglobin, or impaired aggre-
gation in patients receiving cardiac surgery. 
Many studies have reported the development of 
oxygen dependency in a high proportion of such 
patients in the immediate postoperative period. 
We agree that another large trial should be con-
ducted to test the superiority of a liberal transfu-
sion threshold.
We agree that there may be better indicators 
of the need for red-cell transfusion than hemo-
globin level. In the TITRe2 trial, we compared 
hemoglobin thresholds because hemoglobin 
level is currently used to inform most decisions 
regarding whether or not to initiate red-cell 
transfusions. However, using ScvO2 to guide deci-
sion making also has limitations. First, global 
oxygen uptake can be normal when regional 
hypoxia is present. Second, ScvO2 does not mea-
sure oxygen utilization — the key therapeutic 
outcome — and there is no evidence that the use 
of ScvO2-guided algorithms improves this out-
come. The result of the trial conducted by Rivers 
et al.1 has not been replicated.
When planning the TITRe2 trial, we surveyed 
transfusion thresholds and found a range of 
7.5 to 9.0 g per deciliter. No hospital used a more 
restrictive threshold. We expected a between-
group difference in hemoglobin level of approxi-
mately 1 g per deciliter; a difference of 1.5 g per 
deciliter could never have been achieved even 
with perfect adherence, because 100% of par-
ticipants in the liberal-threshold group must 
have breached the level of 9.0 g per deciliter, but 
only 33% of participants in the restrictive-
threshold group were expected to breach 7.5 g per 
deciliter.
The numbers of patients alive and free from 
the composite outcome at 3 months were 599 
(63.5%) in the restrictive-threshold group and 
638 (66.3%) in the liberal-threshold group. Sensi-
tivity analyses of time-to-event outcomes, in 
which data on deceased patients were censored 
at the longest period of observed time, produced 
hazard ratios for discharge from the ICU of 0.94 
(95% confidence interval [CI], 0.86 to 1.03; 
P = 0.20) and discharge from the hospital of 0.98 
(95% CI, 0.90 to 1.07; P = 0.71), findings that are 
consistent with those shown in Table 3 of our 
article. Analysis of the primary outcome as time-
to-event (Fig. S3 in the Supplementary Appendix 
of the article, available at NEJM.org) produced 
a hazard ratio of 1.07 (95% CI, 0.92 to 1.25; 
P = 0.37) after accounting for the competing risk 
of death.
Finally, in our study, more than 80% of pa-
tients underwent randomization within 24 hours 
of leaving the operating theater. The odds ratio 
for the primary outcome was similar for elective 
and urgent cases (post hoc test for interaction, 
P = 0.23).
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